FIENI, CRISTIANO
 Distribuzione geografica
Continente #
EU - Europa 102
NA - Nord America 76
AS - Asia 38
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 219
Nazione #
US - Stati Uniti d'America 75
IT - Italia 45
IE - Irlanda 19
SG - Singapore 19
IN - India 14
SE - Svezia 14
RU - Federazione Russa 8
FI - Finlandia 6
DE - Germania 4
EG - Egitto 2
NL - Olanda 2
AT - Austria 1
BY - Bielorussia 1
CA - Canada 1
EU - Europa 1
GB - Regno Unito 1
JP - Giappone 1
KZ - Kazakistan 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
TH - Thailandia 1
UA - Ucraina 1
Totale 219
Città #
Dublin 19
Chandler 18
Singapore 12
Chennai 11
Pescara 11
Romola 7
Princeton 6
Chieti 5
Helsinki 5
Santa Clara 4
Altamura 3
Lanciano 3
Wilmington 3
Ashburn 2
Frankfurt am Main 2
Irsina 2
Los Angeles 2
Montesilvano Marina 2
Perugia 2
Pune 2
Silver Spring 2
Almaty 1
Andover 1
Coimbatore 1
Kopeysk 1
Lappeenranta 1
Liberty Lake 1
Macao 1
Macerata 1
Milan 1
Moscow 1
Nuremberg 1
Orlando 1
Oxford 1
Rostov-on-Don 1
Sacramento 1
San Giovanni Teatino 1
Seattle 1
Toronto 1
Totale 141
Nome #
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival 53
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival 44
null 38
null 35
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome 29
null 21
Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways 12
Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing 6
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival 4
Nanomedicine for cancer patient-centered care 4
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs 3
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality 2
Totale 251
Categoria #
all - tutte 1.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 4 3 3 5 2 0 1 0 2 3
2022/202390 4 11 2 5 6 13 1 6 13 22 7 0
2023/202451 3 5 2 0 0 14 10 9 0 1 0 7
2024/202587 7 12 28 21 12 7 0 0 0 0 0 0
Totale 251